Literature DB >> 11730042

The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. Associazione Italiana Studi Psoriasi.

A F Finzi1, L G Mantovani, A Belisari.   

Abstract

The objective of this study was to assess the cost of caring for patients with psoriasis in Italy according to the AISP study (Associazione Italiana Studi Psoriasi or Italian Association for Studies on Psoriasis), involving 104 university and hospital centres and 7992 patients in 1994. The mean yearly cost of care for a single patient was calculated at 905 Euros. Hospitalization accounted for more than four-fifths of the costs, therapy for about one-eighth (systemic therapies were the most expensive) and office visits and day hospitals for the remainder. In our study series less than 20% of patients accounted for more than 90% of the total costs.

Entities:  

Mesh:

Year:  2001        PMID: 11730042

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Cost-effectiveness of treatment with etanercept for psoriasis in Sweden.

Authors:  Christopher Knight; Josephine Mauskopf; Mats Ekelund; Amitabh Singh; Shiyi Yang; Robert Boggs
Journal:  Eur J Health Econ       Date:  2011-03-06

Review 2.  Economic burden of psoriatic arthritis.

Authors:  Christoph Ackermann; Arthur Kavanaugh
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy.

Authors:  Federico Spandonaro; Fabio Ayala; Enzo Berardesca; Sergio Chimenti; Giampiero Girolomoni; Patrizia Martini; Andrea Peserico; Barbara Polistena; Antonio Puglisi Guerra; Gino Antonio Vena; Gianfranco Altomare; Piergiacomo Calzavara Pinton
Journal:  BioDrugs       Date:  2014-06       Impact factor: 5.807

4.  Treatment costs of psoriasis in a tertiary-level clinic.

Authors:  Anssi Mustonen; Mauri Leino; Kalle Mattila; Leena Koulu; Risto Tuominen
Journal:  BMC Health Serv Res       Date:  2014-08-15       Impact factor: 2.655

Review 5.  Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective.

Authors:  Lorenzo Mantovani; Massimo Medaglia; Patrizio Piacentini; Marcella Tricca; Gino Antonio Vena; Antonietta Vozza; Gabriella Castellino; Alessandro Roccia
Journal:  Dermatol Ther (Heidelb)       Date:  2016-04-15

6.  Moderate and severe plaque psoriasis: cost-of-illness study in Italy.

Authors:  Gl Colombo; Gf Altomare; K Peris; P Martini; G Quarta; M Congedo; A Costanzo; A Di Cesare; E Lapucci; S Chimenti
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

7.  Cost-of-illness in psoriasis: comparing inpatient and outpatient therapy.

Authors:  Sabine I B Steinke; Wiebke K Peitsch; Alexander Ludwig; Matthias Goebeler
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.